James Huang
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About James Huang
James Huang was last confirmed as Board Member at Alaunos Therapeutics, Inc. (TCRT) in a filing dated April 25, 2023. Earlier roles on record: Chairman at Alaunos Therapeutics, Inc. (TCRT) until September 22, 2023. Alaunos Therapeutics, Inc. reported in an 8-K filed September 28, 2023 that James Huang resigned as Chairman and member of the board of directors, effective September 22, 2023. Windtree Therapeutics Inc /De/ reported in an 8-K filed April 19, 2023 that James Huang resigned as chairman of the board of directors, effective April 18, 2023. James Huang has spoken on 1 earnings call across 1 company, most recently for Alaunos Therapeutics, Inc. on May 6, 2021.
“On September 22, 2023, James Huang resigned as Chairman and member of the board of directors (the "Board") of Alaunos Therapeutics, Inc. (the "Company") with immediate effect in order to focus on other business pursuits.”
“On April 18, 2023, Windtree Therapeutics, Inc. (the “Company”) received a letter from James Huang announcing his decision to resign from his position as the Company’s chairman of the board of directors, effective immediately (the “Resignation Letter”).”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Start not stated–2023-04-25
Last confirmed by a filing; no departure on record
-
Start not stated–2023-09-22
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.